Prevalence, clinical features, and causes of vision loss among patients with ocular toxocariasis

Retina

Volumn 25, Issue 8, 2005, Pages 1005-1013

  Stewart, Jay M ^a   Cubillan, Leo D P ^a   Cunningham Jr , Emmett T ^b,c,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Eyetech Pharmaceuticals Inc ^*  (United States)

^d Eyetech Pharmaceuticals Inc   (United States)

Author keywords

Helminth; Ocular toxocariasis; Posterior uveitis

Indexed keywords

ADOLESCENT; ADULT; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DEMOGRAPHY; DISEASE SEVERITY; ENDOPHTHALMITIS; EYE INFECTION; FEMALE; GRANULOMA; HUMAN; MALE; MEDICAL RECORD; PREVALENCE; RETINA DETACHMENT; RETINA MACULA CYSTOID EDEMA; RETINA MACULA LUTEA; REVIEW; TOXOCARIASIS; UVEITIS; VISUAL IMPAIRMENT; AGE DISTRIBUTION; ANIMAL; ARTICLE; BLOOD; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOLOGY; INFANT; ISOLATION AND PURIFICATION; PARASITOLOGY; PRESCHOOL CHILD; SEX RATIO; TOXOCARA CANIS; UNITED STATES; VISUAL DISORDER; VITREOUS BODY;

HELMINTH ANTIBODY;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ANIMALS; ANTIBODIES, HELMINTH; CALIFORNIA; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; EYE INFECTIONS, PARASITIC; FEMALE; HUMANS; INFANT; MACULAR EDEMA, CYSTOID; MALE; PREVALENCE; RETINAL DETACHMENT; SEX DISTRIBUTION; TOXOCARA CANIS; TOXOCARIASIS; UVEITIS, POSTERIOR; VISION DISORDERS; VITREOUS BODY;

EID: 33644874231     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006982-200512000-00009     Document Type: Review

References (46)

1. Cunningham ET Jr. Uveitis in children. Ocular Immunol Inflamm 2000;8:251-261.
2. Darrell RW, Wagener HP, Kurland LT. Epidemiology of uveitis: incidence and prevalence in a small urban community. Arch Ophthalmol 1962;68:502-514.
3. Vadot E, Barth E, Billet P. Epidemiology of uveitis: preliminary results of a prospective study in Savoy. In: Saari KM, ed. Uveitis Update. Amsterdam: Elsevier Science Publishers; 1984:13.
4. Perkins ES, Folk J. Uveitis in London and Iowa. Ophthalmologica 1984;189:36-40.
5. Henderly DE, Genstler AJ, Smith RE, Rao NA. Changing pattern of uveitis. Am J Ophthalmol 1987;103:131-136.
6. Rodriguez A, Calonge M, Pedroza-Seres M, et al. Referral patterns of uveitis in a tertiary eye care center. Arch Ophthalmol 1996;114:593-599.
7. Shields JA. Ocular toxocariasis: a review. Surv Ophthalmol 1984;28:361-381.
8. Duguid IM. Chronic endophthalmitis due to Toxocara. Br J Ophthalmol 1961;45:705-717.
9. Howard GM, Ellsworth RM. Differential diagnosis of retinoblastoma. Am J Ophthalmol 1965;60:610-616.
10. Perkins ES. Pattern of uveitis in children. Br J Ophthalmol 1966;50:169-185.
11. Zinkham WH. Visceral larva migrans due to Toxocara as a cause of eosinophilia. Johns Hopkins Med J 1968;123:41-47.
12. Wilkinson CP, Welch RB. Intraocular Toxocara. Am J Ophthalmol 1971;71:921-930.
13. Biglan AW, Glickman LT, Lobes LA. Serum and vitreous Toxocara antibody in nematode endophthalmitis. Am J Ophthalmol 1979;88:898-901.
14. Pollard ZF, Jarrett WH, Hagler WS, Allain DS. ELISA for diagnosis of ocular toxocariasis. Ophthalmology 1979;86:743-749.
15. Schantz PM, Meyer D, Glickman LT. Clinical, serologic, and epidemiologic characteristics of ocular toxocariasis. Am J Trop Med Hyg 1979;28:24-28.
16. Hagler WS, Pollard ZF, Jarrett WH, Donnelly EH. Results of surgery for ocular Toxocara canis. Ophthalmology 1981;88:1081-1086.
17. Clemett RS, Tuft SJ. Toxocariasis: a neglected entity. N Z Med J 1983;96:517-519.
18. Rodriguez A. Early pars plana vitrectomy in chronic endophthalmitis of toxocariasis. Graefes Arch Clin Exp Ophthalmol 1986;224:218-220.
19. Small KW, McCuen BW, de Juan E, Machemer R. Surgical management of retinal traction caused by toxocariasis. Am J Ophthalmol 1989;108:10-14.
20. Wan WL, Cano MR, Pince KJ, Green RL. Echographic characteristics of ocular toxocariasis. Ophthalmology 1991;98:28-32.
21. Zygulska-Mach H, Krukar-Baster K, Ziobrowski S. Ocular toxocariasis in children and youth. Doc Ophthalmol 1993;84:145-154.
22. Gillespie SH, Dinning WJ, Voller A, Crowcroft NS. The spectrum of ocular toxocariasis. Eye 1993;7:415-418.
23. Yoshida M, Shirao Y, Asai H, et al. A retrospective study of ocular toxocariasis in Japan: correlation with antibody prevalence and ophthalmological findings in patients with uveitis. J Helminthol 1999;73:357-361.
24. Amin HI, McDonald HR, Han DP, et al. Vitrectomy update for macular traction in ocular toxocariasis. Retina 2000;20:80-85.
25. Park SP, Park I, Park HY, Lee SU, Huh S, Magnaval JF. Five cases of ocular toxocariasis confirmed by serology. Korean J Parasitol 2000;38:267-273.
26. Weiner A, BenEzra D. Clinical patterns and associated conditions in chronic uveitis. Am J Ophthalmol 1991;112:151-158.
27. Schlaegel TF Jr. Differential diagnosis of uveitis. Ophthalmol Digest 1973;35:34-38.
28. Hogan MJ, Kimura SJ, Thygeson P. Signs and symptoms of uveitis: anterior uveitis. Am J Ophthalmol 1959;47:155-170.
29. Kimura SJ, Thygeson P, Hogan MJ. Signs and symptoms of uveitis: classification of the posterior manifestations of uveitis. Am J Ophthalmol 1959;47:71-76.
30. Bloch-Michel E, Nussenblatt RB. International Uveitis Study Group recommendations for the evaluation of intraocular inflammatory disease. Am J Ophthalmol 1987;130:234-235.
31. Barisani-Asenbauer T, Maca SM, Hauff W, et al. Treatment of ocular toxocariasis with albendazole. J Ocular Pharmacol Ther 2001;17:287-294.
32. Taylor MRH. The epidemiology of ocular toxocariasis. J Helminthol 2001;75:109-118.
33. Yokoi K, Goto H, Sakai J, Usui M. Clinical features of ocular toxocariasis in Japan. Ocul Immunol Inflamm 2003;11:269-275.
34. Good B, Holland CV, Taylor MRH, Larragy J, Moriarty P, O'Regan M. Ocular toxocariasis in schoolchildren. Clin Infect Dis 2004;39:173-178.
35. Brown DH. Ocular Toxocara canis. J Pediatr Ophthalmol 1970;7:182-191.
36. Dean Hart JC, Raistrick ER. Adult toxocariasis: uniocular retinal lesions in the 20- to 50-year age group. Trans Ophthalmol Soc U K 1977;97:164-167.
37. Overgaauw PA. Aspects of Toxocara epidemiology: human toxocarosis. Crit Rev Microbiol 1997;23:215-231.
38. Watzke RC, Oaks JA, Folk JC. Toxocara canis infection of the eye. Arch Ophthalmol 1984;102:282-291.
39. Cella W, Ferreira E, Torigoe AM, Macchiaverni-Filho N, Balarin V. Ultrasound biomicroscopy findings in peripheral vitreoretinal toxocariasis. Eur J Ophthalmol 2004;14:132-136.
40. Mirdha BR, Khokar SK. Ocular toxocariasis in a North Indian population. J Trop Pediatr 2002;48:328-330.
41. Magnaval JF, Malard L, Morassin B, Fabre R. Immunodiagnosis of ocular toxocariasis using Western-blot for the detection of specific anti-Toxocara IgG and CAP for the measurement of specific anti-Toxocara IgE. J Helminthol 2002;76:335-339.
42. Shields JA, Felberg NT, Federman JF. Discussion of presentation by Dr. Zane F. Pollard, et al. Ophthalmology 1979;86:750-752.
43. Pollard ZF. Long-term follow-up in patients with ocular toxocariasis as measured by ELISA titers. Ann Ophthalmol 1987;19:167-169.
44. Felberg NT, Shields JA, Federman JL. Antibody to Toxocara canis in the aqueous humor. Arch Ophthalmol 1981;99:1563-1564.
45. Mulvihill A, Bowell R, Lanigan B, O'Keefe M. Uniocular childhood blindness: a prospective study. J Pediatr Ophthalmol Strabismus 1997;34:111-114.
46. Dinning WJ, Gillespie SH, Cooling RJ, Maizels RM. Toxocariasis: a practical approach to management of ocular disease. Eye 1988;2:580-582.